Publication:
Citalopram-induced SIADH in a hypertensive patient on salt restricted diet

dc.contributor.authorTOPÇUOĞLU, VOLKAN
dc.contributor.authorsBez, Yasin; Aktolga, Serdal; Balci, Merih; Nurmedov, Serdar; Topcuoglu, VoLkan
dc.date.accessioned2022-03-12T17:32:34Z
dc.date.accessioned2026-01-11T13:24:25Z
dc.date.available2022-03-12T17:32:34Z
dc.date.issued2007
dc.description.abstractHyponatraemia is a very rare but potentially fatal complication of SSRIs and citalopram therapy, especially during the first weeks of treatment and for those who concomitantly use medications known to cause hyponatraemia. We present a 54-year-old hypertensive female patient who was admitted to the hospital with drowsiness, paresthesia, fatigue, nausea, vomiting and visual hallucinations and who was diagnosed to have syndrome of inappropriate secretion of antidiuretic hormone (SIADH) due to citalopram. All her presenting symptoms disappeared after discontinuation of citalopram therapy, fluid restriction and a careful hypertonic saline infusion. This case suggests that SIADH may develop among hypertensive patients, especially when they use diuretics or follow a salt restricted diet.
dc.identifier.doi10.1177/0269881106073596
dc.identifier.issn0269-8811
dc.identifier.pubmed17092960
dc.identifier.urihttps://hdl.handle.net/11424/228625
dc.identifier.wosWOS:000249329900014
dc.language.isoeng
dc.publisherSAGE PUBLICATIONS LTD
dc.relation.ispartofJOURNAL OF PSYCHOPHARMACOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectcitalopram
dc.subjectSIADH
dc.subjecthyponatraemia
dc.subjectdiet
dc.subjectSEROTONIN REUPTAKE INHIBITORS
dc.subjectHYPONATREMIA
dc.subjectSERTRALINE
dc.subjectFLUOXETINE
dc.subjectSECRETION
dc.subjectVASOPRESSIN
dc.subjectPAROXETINE
dc.titleCitalopram-induced SIADH in a hypertensive patient on salt restricted diet
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage667
oaire.citation.issue6
oaire.citation.startPage665
oaire.citation.titleJOURNAL OF PSYCHOPHARMACOLOGY
oaire.citation.volume21

Files